GlaxoSmithKline Pharmaceuticals Limited — Others, 27-06-2025: Action(s) initiated or orders passed

GlaxoSmithKline Pharmaceuticals Limited has received a tax demand of Rs. 3.39 crore from West Bengal GST authorities related to the period April 2017 to March 2018. The demand arises from disallowance of transitional credit claimed under TRAN 1 and TRAN 2. The amount includes equal parts of tax and penalty, with interest yet to be quantified. The company states there is no impact on its financial operations and is currently reviewing the order to decide on further action. This development highlights ongoing tax compliance scrutiny but does not affect current business performance.